HIF1A and liver cancer: These results suggested that CK could inhibit the expression of Bclaf1 in a rat primary liver cancer model and could activate the ubiquitination of HIF-1α to inhibit glycolysis, thereby inhibiting the proliferation of liver cancer cells in vivo.